Advertisement

What’s New

Latest News

News
False Negatives More Prevalent in Endometrial Cancer Screening for Black Women
10/17/2024
A study published in JAMA Oncology found that Black women are more likely to receive false negative results from transvaginal ultrasounds for endometrial cancer compared to White women, highlighting the need for improved diagnostic methods...
A study published in JAMA Oncology found that Black women are more likely to receive false negative results from transvaginal ultrasounds for endometrial cancer compared to White women, highlighting the need for improved diagnostic methods...
A study published in JAMA...
10/17/2024
Journal of Clinical Pathways
Journal of Clinical Pathways
News
FDA Approves Tumor Treating Fields Wearable Device for Patients With Metastatic Non-Small Cell Lung Cancer
10/17/2024
On October 15, 2024, the FDA granted approval to the Optune Lua, a wearable device that delivers Tumor Treating Fields, for treatment of patients with metastatic non-small cell lung cancer.
On October 15, 2024, the FDA granted approval to the Optune Lua, a wearable device that delivers Tumor Treating Fields, for treatment of patients with metastatic non-small cell lung cancer.
On October 15, 2024, the FDA...
10/17/2024
Oncology
Oncology
News
XYRA Announces FDA Label Guidance for Managing Atrial Fibrillation with Budiodarone and Wearable Monitoring Devices
10/17/2024
XYRA Press Release  Key points: Wearable AF monitoring devices are extensively used in routine practice worldwide. The FDA has agreed on the use of AF monitoring devices in clinical trials for budiodarone approval. The FDA...
XYRA Press Release  Key points: Wearable AF monitoring devices are extensively used in routine practice worldwide. The FDA has agreed on the use of AF monitoring devices in clinical trials for budiodarone approval. The FDA...
XYRA Press Release  Key...
10/17/2024
EP Lab Digest
EP Lab Digest
News
Longer Dosing Intervals for COVID-19 mRNA Vaccines Linked to Lower Myocarditis Risk, Study Finds
10/17/2024
COVID-19 mRNA vaccine dosing intervals significantly impact the risk of myocarditis, with longer intervals generally associated with lower risk, particularly in younger individuals and males, according to a study published in Nature...
COVID-19 mRNA vaccine dosing intervals significantly impact the risk of myocarditis, with longer intervals generally associated with lower risk, particularly in younger individuals and males, according to a study published in Nature...
COVID-19 mRNA vaccine dosing...
10/17/2024
Integrated Healthcare Executive
Integrated Healthcare Executive
News
Supplements Under Class I Recall
10/16/2024
All lots of Vail-Bon Jie Yang Wan capsules from 123Herbals are under a Class I recall for being tainted with the undeclared dexamethasone and chlorpheniramine.
All lots of Vail-Bon Jie Yang Wan capsules from 123Herbals are under a Class I recall for being tainted with the undeclared dexamethasone and chlorpheniramine.
All lots of Vail-Bon Jie Yang...
10/16/2024
Pharmacy Learning Network
Pharmacy Learning Network
A person steps onto a scale
News
Neuropsychiatric Side Effects Reported With CB1 Weight-Loss Drug
10/16/2024
Monlunabant was associated with statistically significant weight loss, but the drug was also linked with mild to moderate neuropsychiatric side effects.
Monlunabant was associated with statistically significant weight loss, but the drug was also linked with mild to moderate neuropsychiatric side effects.
Monlunabant was associated with...
10/16/2024
Psych Congress Network
Psych Congress Network
Investigational Drug Improves Motor Function in Patients With SMA
News
Investigational Drug Improves Motor Function in Patients With SMA
10/16/2024
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational...
10/16/2024
Neurology
Neurology

Latest Research

Volume 32 - Issue 6 - September 2024
The Dermatologist
Navigating Women’s Health Dermatology Through Life’s Stages
Vol. 32, Issue 6, Issue October 2024
The Dermatologist
Shared Decision-Making for Older Adult Dermatology Patients
Vol. 32, Issue 5, Issue October 2024

HMP Global Learning Network

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Featured Interviews

Dr Craig Chepke
Exclusive Interview
Dr Craig Chepke Appointed Scientific Director of Psych Congress, to Co-Chair Upcoming Elevate Meeting
05/21/2024
Meagan Thistle
Dr Craig Chepke discusses his aspirations in his new role, shares insights from his career journey, and reflects on the impact of Psych Congress events on his clinical practice.
Dr Craig Chepke discusses his aspirations in his new role, shares insights from his career journey, and reflects on the impact of Psych Congress events on his clinical practice.
Dr Craig Chepke discusses his...
05/21/2024
Psych Congress Network
Nurses Hoberg and Kempf
Videos
Maintaining Composure When Treating and Caring for Patients With Dementia
03/21/2024

Featuring Amber Hoberg, PMHNP-BC, and Brooke Kempf, PMHNP-BC

Featuring Amber Hoberg, PMHNP-BC, and...
Nurses Hoberg and Kempf discuss how clinicians and caregivers alike can maintain composure and patience when treating patients with dementia.
Nurses Hoberg and Kempf discuss how clinicians and caregivers alike can maintain composure and patience when treating patients with dementia.
Nurses Hoberg and Kempf discuss...
03/21/2024
Psych Congress Network
Bradley Corr, MD
Conference Coverage
Rucaparib Maintenance Therapy Improved Progression-Free Survival Among Patients With Recurrent or Metastatic Endometrial Cancer
03/21/2024

Featuring Bradley Corr, MD

Featuring Bradley Corr, MD
At the 2024 SGO Annual Meeting on Women’s Cancers, Bradley Corr, MD, discusses the results from a study evaluating rucaparib maintenance therapy for patients with metastatic or recurrent endometrial cancer.
At the 2024 SGO Annual Meeting on Women’s Cancers, Bradley Corr, MD, discusses the results from a study evaluating rucaparib maintenance therapy for patients with metastatic or recurrent endometrial cancer.
At the 2024 SGO Annual Meeting...
03/21/2024
Oncology
Constantino Peña, MD, Miami Cancer Institute
Videos
The Importance of a Multidisciplinary Approach in Interventional Oncology
03/21/2024

Featuring Constantino Peña, MD

Featuring Constantino Peña, MD ...
Constantino Peña, MD, discusses the importance of a multidisciplinary approach within the field of interventional oncology.
Constantino Peña, MD, discusses the importance of a multidisciplinary approach within the field of interventional oncology.
Constantino Peña, MD, discusses...
03/21/2024
IO Learning
Jing-Zhou Hou, MD, PhD
Videos
Clinical and Demographic Factors Impacting Treatment Selection for Patients With CLL in Community Oncology Settings
03/21/2024

Featuring Jing-Zhou Hou, MD, PhD

Featuring Jing-Zhou Hou, MD, PhD ...
Jing-Zhou Hou, MD, PhD, discusses how the standard of care for CLL has evolved among community oncologists since 2020 and how clinical and demographic factors impact treatment selection.
Jing-Zhou Hou, MD, PhD, discusses how the standard of care for CLL has evolved among community oncologists since 2020 and how clinical and demographic factors impact treatment selection.
Jing-Zhou Hou, MD, PhD,...
03/21/2024
Journal of Clinical Pathways
Jack Jennings, MD, PhD, Washington University in St Louis
Videos
Treatment of Primary and Metastatic Sarcoma
02/06/2024

Featuring Jack Jennings, MD, PhD

Featuring Jack Jennings, MD, PhD ...
At the 2024 SIO Annual Meeting, Jack Jennings, MD, PhD, discussed the role of the interventional oncologist when treating primary or metastatic sarcomas of the bone or soft tissue.
At the 2024 SIO Annual Meeting, Jack Jennings, MD, PhD, discussed the role of the interventional oncologist when treating primary or metastatic sarcomas of the bone or soft tissue.
At the 2024 SIO Annual Meeting,...
02/06/2024
IO Learning
Saby George, MD
Conference Coverage
Subcutaneous Nivolumab Noninferior to Intravenous Administration Among Patients With Clear Cell Renal Cell Carcinoma
01/27/2024

Featuring Saby George, MD 

Featuring Saby George, MD 
Saby George shares insights from the CheckMate 67T evaluating the subcutaneous administration of nivolumab for patients with clear cell renal cell carcinoma, compared with the intravenous administration.
Saby George shares insights from the CheckMate 67T evaluating the subcutaneous administration of nivolumab for patients with clear cell renal cell carcinoma, compared with the intravenous administration.
Saby George shares insights from...
01/27/2024
Oncology
Michiel van der Heijden, MD 
Conference Coverage
Enfortumab Vedotin Plus Pembrolizumab Potential New Standard of Care for Advanced Urothelial Carcinoma in the First-Line Setting
01/26/2024

Featuring Michiel van der Heijden, MD 

Featuring Michiel van der Heijden, MD...
Michiel van der Heijden, MD, discusses the subgroup analyses of the phase 3 EV-302 study, evaluating enfortumab vedotin plus pembrolizumab among patients with locally advanced or metastatic urothelial carcinoma in the first-line setting.
Michiel van der Heijden, MD, discusses the subgroup analyses of the phase 3 EV-302 study, evaluating enfortumab vedotin plus pembrolizumab among patients with locally advanced or metastatic urothelial carcinoma in the first-line setting.
Michiel van der Heijden, MD,...
01/26/2024
Oncology
Thierry André, MD, Saint Antoine Hospital
Videos
Nivolumab Plus Ipilimumab Yields Superior PFS vs Chemotherapy for First-Line Treatment of Metastatic Colorectal Cancer
01/23/2024

Featuring Thierry André, MD

Featuring Thierry André, MD
Thierry Andre, MD, discusses the first results from the CheckMate 8HW study exploring nivolumab plus chemotherapy for the first-line treatment of microsatellite instability-high, mismatch repair-deficient metastatic colorectal cancer.
Thierry Andre, MD, discusses the first results from the CheckMate 8HW study exploring nivolumab plus chemotherapy for the first-line treatment of microsatellite instability-high, mismatch repair-deficient metastatic colorectal cancer.
Thierry Andre, MD, discusses the...
01/23/2024
Oncology
Riccardo Lencioni, MD, University of Pisa School of Medicine
Videos
Addition of Durvalumab, Bevacizumab to TACE for Hepatocellular Carcinoma Improves PFS
01/23/2024

Featuring Riccardo Lencioni, MD

Featuring Riccardo Lencioni, MD ...
Ricardo Lencioni, MD, shares results from the phase 3 EMERALD-1 study which found the addition of durvalumab and bevacizumab to TACE improved progression-free survival among patients with hepatocellular carcinoma, compared with TACE alone.
Ricardo Lencioni, MD, shares results from the phase 3 EMERALD-1 study which found the addition of durvalumab and bevacizumab to TACE improved progression-free survival among patients with hepatocellular carcinoma, compared with TACE alone.
Ricardo Lencioni, MD, shares...
01/23/2024
Oncology

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use